Skip to content

Dermal scarification for the treatment of renal colic.

Dermal scarification versus intramuscular diclofenac sodium injection for the treatment of renal colic. A Prospective Randomised clinical trial.

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12612000233820
Enrollment
210
Registered
2012-02-23
Start date
2012-07-03
Completion date
2013-06-04
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

Intramuscular injection of non-steroid anti-inflammatory drugs (NSAIDs) is the conventional treatment for renal colic. The most com-monly used NSAID for this purpose is diclofenac sodium. In this study we attempt to investigate the effectiveness of an alternative method in the treatment of renal colic, the endodermal injection (Dermal Scarification) of 1ml normal saline at the area of the pain reflection. This technique is not strictly defined and seems to be based on the principles of acupuncture. The method of application and the success of this treatment were orally transferred from older to younger urologists.

Interventions

Endodermal injection (Dermal scarification) of 1ml normal saline at the area of the pain reflection. The injection is administered in participants once only at 8-10 different points intradermally (between the layers of dermis).

Sponsors

Gennimatas General Hospital of Thessaloniki
Lead SponsorHospital

Study design

Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Treatment
Masking
Open (masking not used)

Eligibility

Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Patients with typical renal or ureteral colic symptoms and at least two laboratory results that justify the diagnosis (haematuria, positive stone shadow at KUB, ultrasonographic dilation of the upper urinary tract at the side of pain). 2. Written consent of the patient’s participation in the study

Exclusion criteria

1. Chronic use of analgesic drugs. 2. Use of any analgesic drug during the last 12hours. 3. Use of anticonvulsant during the last 8 hours. 4. Medical history of allergic reaction to NSAIDs. 5. Medical history of stomach ulcer or gastritis.

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026